Bangladesh signs MoU with Indian Company for collecting 3 crores Coronavirus vaccine

▴ Bangladesh signs MoU with Indian Company for collecting 3 crores Coronavirus vaccine
An MoU was signed on 5th Nov between the government of Bangladesh, Beximco Pharmaceutical Ltd and the Serum Institute of India for priority delivery of 3 crores COVID-19 vaccine doses.

The process of development of the vaccine is in the final stages at the University of Oxford and AstraZeneca.

Health Minister of Bangladesh Zahid Maleque and High Commissioner of India to Bangladesh Vikram Doraiswami were present on the occasion along with other senior officials of the Health Ministry of Bangladesh and the two companies.

Calling it a ‘landmark agreement’, Health Minister Zahid Maleque expressed the hope that the people of Bangladesh will get relief from this. He said that initially 1.5 crore people will be vaccinated as each person will require two doses of the vaccine.

High Commissioner Vikram Doraiswami said that the vaccine from India was chosen not only because it was the best price but also because it is most suitable for the conditions for the distribution of the vaccine in Bangladesh.

He said that the vaccine is also one of the most promising candidates which are being brought up to the international regulators. The High Commissioner said that it is the culmination of the agenda that Prime Minister Narendra Modi put forward in March this year when he told SAARC leaders that this battle should be fought together and won together.

Meanwhile, new air service between India and Bangladesh under the air-bubble arrangement started yesterday. Welcoming the start of the new service, Bangladesh State Minister for Civil Aviation Md. Mahbub Ali said that the air-bubble arrangement between the two countries has helped people who need to travel for medical, business, and other purposes. He pointed out that Bangladesh and India enjoyed excellent relations and Prime Minister Sheikh Hasina is working to further strengthen people to people ties between the two countries.

Tags : #Bangladesh #India #AstraZeneca #UniversityofOxford #PMNarendraModi #PMSeikhHasina #COVIDvaccine #LatestPharmaNews6thNov

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Staying Cool in India's Scorching Heat: Heatwave Safety TipsApril 26, 2024
The Dark Side of Neotame (Artificial Sweetener): New Research Raises Concerns about Gut HealthApril 26, 2024
Transforming Brain Healthcare: India's Visionary Task Force for Neurological DisordersApril 25, 2024
The Battle Against Malaria: Rising Trends and Vaccine InnovationsApril 25, 2024
Talc and Asbestos Controversy: Inside Johnson & Johnson's Courtroom StruggleApril 25, 2024
The Hidden Struggles of Parenthood: Addressing Isolation, Loneliness, and BurnoutApril 25, 2024
FDA Confirms Bird Flu Virus Remnants in Pasteurized Milk: Safety and Regulatory InsightsApril 24, 2024
Sarvodaya Hospital Redefines Total Knee Replacement Surgery with Augmented Reality April 23, 2024
Fateh Education announces partnership to expand educational opportunities for Indian studentsApril 23, 2024
10 Strategies to counter disinformation for the healthcare digital ecosystemApril 23, 2024
Is Selling Over-the-Counter (OTC) Drugs in General Stores A Step Towards Affordable Healthcare in IndiaApril 23, 2024
Student Health Crisis: Food Poisoning Incident Strikes Pune Coaching CentreApril 23, 2024
The Impact of Diabetes on Kidney Health: Diabetic Nephropathy ExplainedApril 23, 2024
Toddler Hospitalized After Consuming Expired Chocolates: Health Concerns RaisedApril 23, 2024
After months of diagnostic delay, a migrant worker could access TB services only when a community health worker met himApril 22, 2024
Indian Spices Contaminated with Cancer-Causing Chemical: Hong Kong Food Regulators Issue WarningApril 22, 2024
FTCCI organised a Workshop on Rooftop Kitchen GardeningApril 20, 2024
Children in Cities Exposed to Elevated Lead Levels: Study Reveals Urgent Health ConcernApril 20, 2024
Biocon Ventures into Weight-Loss Drug Market with Semaglutide DevelopmentApril 20, 2024
Innovative AI Assistance Empowers Moscow Doctors to Detect Cervical Spine Issues through MRI ScansApril 20, 2024